258 related articles for article (PubMed ID: 38038364)
1. What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators.
Mulders MCF; de Herder WW; Hofland J
Endocr Rev; 2024 May; 45(3):351-360. PubMed ID: 38038364
[TBL] [Abstract][Full Text] [Related]
2. Carcinoid syndrome: update on the pathophysiology and treatment.
Rubin de Celis Ferrari AC; Glasberg J; Riechelmann RP
Clinics (Sao Paulo); 2018 Aug; 73(suppl 1):e490s. PubMed ID: 30133565
[TBL] [Abstract][Full Text] [Related]
3. Management of carcinoid syndrome: a systematic review and meta-analysis.
Hofland J; Herrera-Martínez AD; Zandee WT; de Herder WW
Endocr Relat Cancer; 2019 Mar; 26(3):R145-R156. PubMed ID: 30608900
[TBL] [Abstract][Full Text] [Related]
4. Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome.
Clement D; Ramage J; Srirajaskanthan R
J Oncol; 2020; 2020():8341426. PubMed ID: 32322270
[TBL] [Abstract][Full Text] [Related]
5. Carcinoid Syndrome: A Review.
Gade AK; Olariu E; Douthit NT
Cureus; 2020 Mar; 12(3):e7186. PubMed ID: 32257725
[TBL] [Abstract][Full Text] [Related]
6. Carcinoid syndrome and serotonin: therapeutic effects of ketanserin.
Robertson JI
Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():53-8. PubMed ID: 2285651
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of the pathophysiology of carcinoid crisis.
Condron ME; Jameson NE; Limbach KE; Bingham AE; Sera VA; Anderson RB; Schenning KJ; Yockelson S; Harukuni I; Kahl EA; Dewey E; Pommier SJ; Pommier RF
Surgery; 2019 Jan; 165(1):158-165. PubMed ID: 30415870
[TBL] [Abstract][Full Text] [Related]
8. [The carcinoid syndrome].
Laplante L; Archambault A; Thibert F
Union Med Can; 1971 Oct; 100(10):1970-84. PubMed ID: 5316830
[No Abstract] [Full Text] [Related]
9. Tachykinins in endocrine tumors and the carcinoid syndrome.
Cunningham JL; Janson ET; Agarwal S; Grimelius L; Stridsberg M
Eur J Endocrinol; 2008 Sep; 159(3):275-82. PubMed ID: 18524798
[TBL] [Abstract][Full Text] [Related]
10. Motilin in plasma and tumor tissues from patients with the carcinoid syndrome. Possible involvement in the increased frequency of bowel movements.
Oberg K; Theodorsson-Norheim E; Norheim I
Scand J Gastroenterol; 1987 Nov; 22(9):1041-8. PubMed ID: 2447632
[TBL] [Abstract][Full Text] [Related]
11. Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors.
Kema IP; de Vries EG; Slooff MJ; Biesma B; Muskiet FA
Clin Chem; 1994 Jan; 40(1):86-95. PubMed ID: 7507008
[TBL] [Abstract][Full Text] [Related]
12. Increased intestinal non-substance P tachykinin concentrations in malignant midgut carcinoid disease.
Makridis C; Theodorsson E; Akerström G; Oberg K; Knutson L
J Gastroenterol Hepatol; 1999 May; 14(5):500-7. PubMed ID: 10355517
[TBL] [Abstract][Full Text] [Related]
13. [Effects of the administration of somatostatin 14 in the carcinoid syndrome. Clinical and biological study of 2 cases].
Guillard JF; Galmiche JP; Chayvialle JA; Kremer M; Comoy E; Lerebours E; Charbonnel B; Colin R
Gastroenterol Clin Biol; 1983 Dec; 7(12):1016-22. PubMed ID: 6141119
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biochemical aspects of the carcinoid syndrome in neuroendocrine tumors of the abdominal and retroperitoneal organs and its impact for the disease prognosis.
Polikarpova SB; Lubimova NV; Ogereliev AS; Britvin TA; Davidov MI
Bull Exp Biol Med; 2009 Nov; 148(5):803-6. PubMed ID: 20396797
[TBL] [Abstract][Full Text] [Related]
15. Fibrosis and carcinoid syndrome: from causation to future therapy.
Druce M; Rockall A; Grossman AB
Nat Rev Endocrinol; 2009 May; 5(5):276-83. PubMed ID: 19444261
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in carcinoid syndrome: A gap to be closed.
Ruggeri RM; Altieri B; Grossrubatcher E; Minotta R; Tarsitano MG; Zamponi V; MIsidori A; Faggiano A; Colao AM;
Rev Endocr Metab Disord; 2022 Jun; 23(3):659-669. PubMed ID: 35292889
[TBL] [Abstract][Full Text] [Related]
17. TELEPRO: Patient-Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World.
Strosberg J; Joish VN; Giacalone S; Perez-Olle R; Fish-Steagall A; Kapoor K; Dharba S; Lapuerta P; Benson AB
Oncologist; 2019 Nov; 24(11):1446-1452. PubMed ID: 31189618
[TBL] [Abstract][Full Text] [Related]
18. Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study.
Lesén E; Björstad Å; Björholt I; Marlow T; Bollano E; Feuilly M; Marteau F; Welin S; Elf AK; Johanson V
Scand J Gastroenterol; 2018 Dec; 53(12):1509-1518. PubMed ID: 30449217
[TBL] [Abstract][Full Text] [Related]
19. Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications.
Fanciulli G; Ruggeri RM; Grossrubatscher E; Calzo FL; Wood TD; Faggiano A; Isidori A; Colao A;
Rev Endocr Metab Disord; 2020 Dec; 21(4):599-612. PubMed ID: 32152781
[TBL] [Abstract][Full Text] [Related]
20. Serotonin, catecholamines, and spontaneous midgut carcinoid flush: plasma studies from flushing and nonflushing sites.
Matuchansky C; Launay JM
Gastroenterology; 1995 Mar; 108(3):743-51. PubMed ID: 7533112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
